T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis

T cell responses to Mycobacterium indicus pranii immunotherapy and adjunctive glucocorticoid therapy in tuberculous pericarditis

Background: In the Investigation of the Management of Pericarditis (IMPI) randomized control, 2x2 factorial trial, Mycobacterium indicus pranii (MIP) immunotherapy, adjunctive corticosteroids or MIP combined with corticosteroids was compared to standard tuberculosis (TB) therapy for tuberculous peri...

Full description

Bibliographic Details
Main Authors: Pia Steigler, Mukesh Chhiba, Veronica Francis, Alana Keyser, Deborah Abrahams, Willem Hanekom, Mpiko Ntsekhe, Thomas J. Scriba
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Vaccine: X
Subjects:
Tuberculous pericarditis
Mycobacteriumindicus pranii immunotherapy
Adjunctive corticosteroid
T cell responses
Online Access:http://www.sciencedirect.com/science/article/pii/S2590136222000377

Internet

http://www.sciencedirect.com/science/article/pii/S2590136222000377

Similar Items